Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

Issue 14 - Minutes of Proceedings - April 4, 2012

OTTAWA, Wednesday, April 4, 2012
(33)

[English]

The Standing Senate Committee on Social Affairs, Science and Technology met this day at 4:15 p.m., in room 2, Victoria Building, the chair, the Honourable Kelvin Kenneth Ogilvie, presiding.

Members of the committee present: The Honourable Senators Callbeck, Cordy, Demers, Dyck, Eggleton, P.C., Martin, Ogilvie, Seidman, Seth and Verner, P.C. (10).

In attendance: Sonya Norris, Analyst, Parliamentary Information and Research Service, Library of Parliament.

Also in attendance: The official reporters of the Senate.

Pursuant to the order of reference adopted by the Senate on Thursday, November 17, 2011, the committee continued its study on prescription pharmaceuticals in Canada. (For complete text of the order of reference, see proceedings of the committee, Issue No. 12.)

WITNESSES:

Health Canada:

Paul Glover, Assistant Deputy Minister, Health Products and Food Branch (HPFB);

Barbara Sabourin, Director General, Therapeutic Products Directorate (TPD), HPFB;

Dr. John Patrick Stewart, A/Director General, Clinical Trials Office, TPD, HPFB.

Office of the Auditor General of Canada:

Neil Maxwell, Assistant Auditor General;

Louise Dubé, Principal.

The chair made a statement.

Mr. Maxwell and Mr. Glover each made a statement and, together with Ms. Sabourin, Dr. Stewart and Ms. Dubé, answered questions.

At 5:07 p.m., the committee adjourned to the call of the chair.

ATTEST:

Jessica Richardson

Clerk of the Committee